Lennart Holterman

Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

Peter Abbink, Angelique A. C. Lemckert, Bonnie A. Ewald et al. · Journal of Virology · 2007 · 516 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

D.M. Roberts, Anjali Nanda, Menzo Havenga et al. · Nature · 2006 · 489 citations

Life Sciences, Immunology, Molecular Biology +14

Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity

Angelique A. C. Lemckert, Shawn M. Sumida, Lennart Holterman et al. · Journal of Virology · 2005 · 156 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5

Lennart Holterman, Ronald Vogels, Remko van der Vlugt et al. · Journal of Virology · 2004 · 143 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Age Dependence of Adenovirus-Specific Neutralizing Antibody Titers in Individuals from Sub-Saharan Africa

Anna R. Thorner, Ronald Vogels, Jorn Kaspers et al. · Journal of Clinical Microbiology · 2006 · 112 citations · Full text

Life Sciences, Infectious Diseases, Pediatrics +15